Medical / Pharmaceuticals News and Press Releases

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 1 of 2

Yet again, MedPAC acknowledges need to strengthen Medicare payments: 1/19/2026 11:56:12 AM; The Medicare Payment Advisory Commission (MedPAC) voted to address inadequate payment for Medicare physician services under current law, once again underscoring a longstanding policy failure that is widely recognized but remains unresolved.
The importance of childhood vaccinations: 1/19/2026 11:37:47 AM; Vaccines save millions of lives each year. The clinical evidence showing that childhood vaccines are safe and effective hasn’t changed. Kaiser Permanente’s doctors and other clinicians continue to recommend the childhood vaccines that have been recommended for years.
Medical Imaging Division Announces Rich Fabian as New Board Chair: 1/19/2026 11:26:52 AM; AdvaMed, the Medtech Association, today announced that Rich Fabian, president and CEO of FUJIFILM Sonosite, will serve as the chair of the Medical Imaging division’s board of directors.
Families in Sudan pushed to the brink amidst brutal conflict and famine as WFP resources dry up: 1/15/2026 4:01:32 PM; As Sudan marks more than 1,000 days of brutal conflict this month, what has become the world’s largest hunger and displacement crisis shows no signs of abating.
Allegations related to Medicare risk adjustment resolved: 1/15/2026 1:40:30 PM; Kaiser Permanente has reached a settlement agreement with the U.S. Department of Justice to resolve a dispute regarding certain documentation practices impacting some Medicare Advantage risk adjustment submissions between 2009 and 2018.
Updated WHO manuals provide guidance to strengthen foodborne disease surveillance and response capacities worldwide: 1/15/2026 1:38:31 PM; When a food safety incident is identified, INFOSAN members must act quickly. Timely detection, clear information, and coordinated response determine whether an event remains local or becomes an international emergency.
AMA statement on restoring federal grants for mental health and SUD care: 1/15/2026 1:07:54 PM; Statement attributable to: David H. Aizuss, MD Chair, AMA Board of Trustees “The American Medical Association (AMA) is pleased that critical federal funding for mental health and addiction programs is being restored.
Novel Liquid Biopsy Technology Lowers Barriers for More Efficient Cancer Diagnostics: 1/14/2026 1:15:16 PM; A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow.
Cardinal Health introduces ContinuCare™ Pathway; announces relationship with Publix: 1/14/2026 11:48:16 AM; Cardinal Health (NYSE: CAH) introduced ContinuCare™ Pathway, a unique pharmacy-to-supplier referral pathway program designed to help retail pharmacies seamlessly refer patients to Cardinal Health at-Home Solutions for the rapid fulfillment and direct-to-patient home delivery of diabetes supplies covered under the medical benefit, including continuous glucose monitors.
AMA announces recipients of $12 million precision education grant program: 1/13/2026 12:42:15 PM; The American Medical Association (AMA) today announced the recipients of $12 million in grant funding aimed at modernizing how physicians learn across their career.
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation: 1/12/2026 3:15:25 PM; The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia: 1/12/2026 3:03:48 PM; Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced that its spin-out company, Neurosterix, has started a Phase 1 clinical study of NTX-253.
AMA 2025 report on substance use and treatment: 1/12/2026 2:40:07 PM; The American Medical Association (AMA) today released its 2025 report (PDF) on the nation’s overdose epidemic, showing that while opioid-related overdose deaths declined last year, the epidemic remains widespread and increasingly complex, driven by mixing opioids and other substances and an unpredictable illicit drug supply. Overdose deaths declined from more than 110,000 …
Why are men more likely to develop multiple myeloma than women?: 1/12/2026 2:10:18 PM; Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, provides insights that may help to explain this disparity.
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award: 1/8/2026 3:34:15 PM; Johnson & Johnson today announced Tony Hunter, Ph.D., of the Salk Institute as the recipient of the 2025 Dr. Paul Janssen Award for Biomedical Research.
AMA applauds Dietary Guidelines, announces commitments on nutrition: 1/8/2026 2:03:16 PM; The following statement is attributable to: Bobby Mukkamala, MD President, American Medical Association “The American Medical Association (AMA) applauds the Administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses.
Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins Driving Alzheimer’s and Cancer: 1/8/2026 12:05:13 PM; Topos Bio, a biotechnology company pioneering AI-driven drug discovery for intrinsically disordered proteins (IDPs), today emerged from stealth with $10.5M in seed funding from Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao (CEO of Unconventional AI).
Bausch + Lomb to Present New Real-World Outcomes on Zenlens® Scleral Lenses at Global Specialty Lens Symposium: 1/7/2026 7:59:51 PM; Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced that it will present new real-world outcomes on Zenlens scleral lenses during four presentations, including one oral presentation, at the Global Specialty Lens Symposium, taking place Jan.
Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections: 1/7/2026 7:47:58 PM; Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with Prokaryotics Inc., a privately held US-based biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs.
DHL Supply Chain Expands Life Sciences & Healthcare Capabilities With New Center of Excellence: 1/7/2026 7:32:18 PM; With U.S. pharmaceutical logistics growing at an annual rate of eight percent,1 DHL Supply Chain is reinforcing its leadership in the life sciences and healthcare market through the completion of a one-million-square-foot distribution center of excellence located in Annville, Pa.